Free Trial

LogicMark (LGMK) Competitors

LogicMark logo
$0.0040 0.00 (0.00%)
As of 03:56 PM Eastern

LGMK vs. NURO, IINN, LUCY, POAI, TNON, SINT, STRR, PSTV, BLAC, and QNRX

Should you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include NeuroMetrix (NURO), Inspira Technologies Oxy B.H.N. (IINN), Innovative Eyewear (LUCY), Predictive Oncology (POAI), Tenon Medical (TNON), Sintx Technologies (SINT), Star Equity (STRR), Plus Therapeutics (PSTV), Bellevue Life Sciences Acquisition (BLAC), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry.

LogicMark vs. Its Competitors

LogicMark (NASDAQ:LGMK) and NeuroMetrix (NASDAQ:NURO) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, LogicMark had 2 more articles in the media than NeuroMetrix. MarketBeat recorded 2 mentions for LogicMark and 0 mentions for NeuroMetrix. LogicMark's average media sentiment score of 0.44 beat NeuroMetrix's score of 0.00 indicating that LogicMark is being referred to more favorably in the media.

Company Overall Sentiment
LogicMark Neutral
NeuroMetrix Neutral

NeuroMetrix has lower revenue, but higher earnings than LogicMark. NeuroMetrix is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LogicMark$9.88M0.23-$14.55M-$223.500.00
NeuroMetrix$3.03M3.09-$6.53M-$4.59-0.99

LogicMark has a net margin of -141.96% compared to NeuroMetrix's net margin of -203.71%. NeuroMetrix's return on equity of -42.56% beat LogicMark's return on equity.

Company Net Margins Return on Equity Return on Assets
LogicMark-141.96% -124.91% -92.05%
NeuroMetrix -203.71%-42.56%-39.26%

LogicMark has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500.

7.9% of LogicMark shares are owned by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are owned by institutional investors. 1.3% of LogicMark shares are owned by insiders. Comparatively, 7.3% of NeuroMetrix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

NeuroMetrix received 284 more outperform votes than LogicMark when rated by MarketBeat users.

CompanyUnderperformOutperform
LogicMarkN/AN/A
NeuroMetrixOutperform Votes
284
56.13%
Underperform Votes
222
43.87%

Summary

NeuroMetrix beats LogicMark on 9 of the 14 factors compared between the two stocks.

Get LogicMark News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LGMK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGMK vs. The Competition

MetricLogicMarkSurgical appliances & supplies IndustryIndustrials SectorNASDAQ Exchange
Market Cap$2.31M$9.14B$7.73B$8.50B
Dividend YieldN/A1.26%4.56%4.17%
P/E Ratio0.0020.6125.4019.64
Price / Sales0.2345.06113.82152.17
Price / CashN/A19.6726.8434.64
Price / Book0.005.084.194.60
Net Income-$14.55M$284.66M$807.24M$248.06M
7 Day PerformanceN/A-3.73%0.50%-1.02%
1 Month PerformanceN/A-7.34%8.63%3.51%
1 Year PerformanceN/A-22.76%25.50%12.68%

LogicMark Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGMK
LogicMark
0.4951 of 5 stars
$0.00
flat
N/A-100.0%$2.31M$9.88M0.0020Positive News
Short Interest ↑
Gap Up
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+17.9%$9.37M$3.03M-0.9920High Trading Volume
IINN
Inspira Technologies Oxy B.H.N.
2.2431 of 5 stars
$0.73
+0.6%
$2.00
+174.0%
-60.9%$9.16MN/A0.0020Short Interest ↑
LUCY
Innovative Eyewear
1.2074 of 5 stars
$2.83
-1.4%
N/A-73.6%$8.76M$1.71M-0.299Short Interest ↓
POAI
Predictive Oncology
1.9646 of 5 stars
$0.91
-2.9%
$3.00
+229.0%
-26.7%$8.14M$1.73M-0.3030News Coverage
Short Interest ↑
Gap Down
TNON
Tenon Medical
2.8124 of 5 stars
$1.01
+0.5%
$4.67
+364.3%
+46.9%$7.63M$3.28M-0.048News Coverage
Short Interest ↓
SINT
Sintx Technologies
2.1754 of 5 stars
$2.85
+0.4%
$28.00
+882.5%
-35.3%$7.15M$1.23M-0.0640Short Interest ↑
STRR
Star Equity
2.8275 of 5 stars
$2.10
-1.4%
$5.00
+138.1%
-51.7%$6.82M$57.17M-0.82460Short Interest ↑
High Trading Volume
PSTV
Plus Therapeutics
2.3138 of 5 stars
$0.35
+7.0%
$11.67
+3,249.6%
-84.1%$5.92M$4.91M-0.1420Short Interest ↓
Gap Up
BLAC
Bellevue Life Sciences Acquisition
N/A$1.36
-2.9%
N/A-84.5%$5.50MN/A0.00N/AGap Up
QNRX
Quoin Pharmaceuticals
1.5326 of 5 stars
$8.52
-3.4%
N/A-65.9%$5.19MN/A-2.104Short Interest ↓

Related Companies and Tools


This page (NASDAQ:LGMK) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners